prediabetes and glp 1 Comparing Glucagon‐like peptide‐1 receptor agonists versus metformin in drug‐naive patients: A nationwide cohort study - Sørensen - 2024 - Journal of Diabetes Glucagon-Like Peptide-1: New Regulator in

Alli works in your digestive system by blocking about 25% of the fat you eat from being absorbed

author reply 1833

Migratory joint pain with no clear cause is one of the most consistent features of late Lyme

Key lipid changes with GLP-1 receptor agonists include: Triglycerides: 15-25% reduction Total cholesterol: 3-8% reduction LDL cholesterol: 3-7% reduction HDL cholesterol: 2-5% increase Non-HDL cholesterol: 5-10% reduction The SELECT cardiovascular outcomes trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease who were receiving standard background care

People with cardiovascular risk factors see meaningful improvements